Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Saunders

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Biochemical Pharmacology|May 15, 1974
Effects of SC-26096(2-methyl-3-oxo-2azabicyclo(2.2.2.)octan-6-exo-yl 5-(4-biphenylyl)-3-methyl valerate), a new hypolipidemic agent, on mitochondrial respiration and oxidative phosphorylationC R Mackerer, J R Haettinger, R N Saunders, et al.
Advances in Prostaglandin and Thromboxane Research|January 1, 1980
Synthesis and biological activities of arachidonic and alpha- and beta-alkyl-substituted arachidonic acid derivativesC D Liang, J S Baran, J E Miller, et al.
The American Journal of Physiology|April 1, 1989
Release of platelet-activating factor from ischemic-reperfused rabbit heartG Montrucchio, G Alloatti, C Tetta, et al.
Immunopharmacology|December 1, 1984
Effect of platelet activating factor on endothelial permeability to plasma macromoleculesD A Handley, C M Arbeeny, M L Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412D A Handley, R G Van Valen, M K Melden, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2000
Workload generated by a living donor programme for renal transplantationR N Saunders, R Elwell, G J Murphy, et al.
Thrombosis and Haemostasis|April 7, 1987
In vitro and in vivo pharmacological profiles of the PAF receptor antagonist SRI 63-675D A Handley, R G Van Valen, C M Winslow, et al.
Transplantation Proceedings|December 26, 2001
Normothermic perfusion of ischaemically damaged porcine kidneys: an evaluation of ex vivo functionM S Metcalfe, C D Mann, J R Waller, et al.
International Archives of Allergy and Applied Immunology|January 1, 1989
Effects of combined receptor antagonists of leukotriene D4 (LTD4) and platelet-activating factor (PAF) on rhesus airway responses to LTD4, PAF and antigenR Patterson, K E Harris, P R Bernstein, et al.
Transplantation Proceedings|August 15, 2002
A randomized trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathyM S Metcalfe, S Jain, J R Waller, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|May 15, 1974
Effects of SC-26096(2-methyl-3-oxo-2azabicyclo(2.2.2.)octan-6-exo-yl 5-(4-biphenylyl)-3-methyl valerate), a new hypolipidemic agent, on mitochondrial respiration and oxidative phosphorylationC R Mackerer, J R Haettinger, R N Saunders, et al.
Advances in Prostaglandin and Thromboxane Research|January 1, 1980
Synthesis and biological activities of arachidonic and alpha- and beta-alkyl-substituted arachidonic acid derivativesC D Liang, J S Baran, J E Miller, et al.
The American Journal of Physiology|April 1, 1989
Release of platelet-activating factor from ischemic-reperfused rabbit heartG Montrucchio, G Alloatti, C Tetta, et al.
Immunopharmacology|December 1, 1984
Effect of platelet activating factor on endothelial permeability to plasma macromoleculesD A Handley, C M Arbeeny, M L Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412D A Handley, R G Van Valen, M K Melden, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2000
Workload generated by a living donor programme for renal transplantationR N Saunders, R Elwell, G J Murphy, et al.
Thrombosis and Haemostasis|April 7, 1987
In vitro and in vivo pharmacological profiles of the PAF receptor antagonist SRI 63-675D A Handley, R G Van Valen, C M Winslow, et al.
Transplantation Proceedings|December 26, 2001
Normothermic perfusion of ischaemically damaged porcine kidneys: an evaluation of ex vivo functionM S Metcalfe, C D Mann, J R Waller, et al.
International Archives of Allergy and Applied Immunology|January 1, 1989
Effects of combined receptor antagonists of leukotriene D4 (LTD4) and platelet-activating factor (PAF) on rhesus airway responses to LTD4, PAF and antigenR Patterson, K E Harris, P R Bernstein, et al.
Transplantation Proceedings|August 15, 2002
A randomized trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathyM S Metcalfe, S Jain, J R Waller, et al.
Pageof 6